← Leaderboards
Daniel A Laheru
Johns Hopkins University
$1,346,152
Attributed
$1,346,152
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $330.6K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,346,152 · 3
By mechanism
K23$684,450 · 1
R21$661,138 · 1
M01$564 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Elizabeth Marion Jaffee$29,780,612
- Eric L Nuermberger$20,859,483
- Nirbhay Kumar$12,253,206
- Netzahualcoyotl Arroyo Curras$1,651,516
- Zaver M Bhujwalla$35,375,851
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellGemcitabineNeoplasm /Cancer SurgeryNeoplasm /Cancer VaccineNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer Relapse /RecurrenceNeoplasm /Cancer ChemotherapyDrug Design /Synthesis /ProductionColony Stimulating FactorNeoplasm /Cancer Radiation TherapyMetastasisCell LineDelayed HypersensitivityHuman Therapy EvaluationCohortImmune ResponseCombination Cancer TherapyBiopsyDoseBaseGenesHuman SubjectActive ImmunizationClinical Research
Grant awards (8)
Gene modified vaccine in combination with Ipilimumab for advanced pancreatic canc$330,569
R21 · FY2009 · CA · contact PI
Gene modified vaccine in combination with Ipilimumab for advanced pancreatic canc$330,569
R21 · FY2008 · CA · contact PI
STUDY OF CRS-100 ON ADULTS WITH CARCINOMA REFRACTORY AND LIVER METASTASES$564
M01 · FY2007 · RR · contact PI
Gene Modified Cell Lines as Vaccine for Pancreas Cancer$136,890
K23 · FY2006 · CA · contact PI
Gene Modified Cell Lines as Vaccine for Pancreas Cancer$136,890
K23 · FY2005 · CA
Gene Modified Cell Lines as Vaccine for Pancreas Cancer$136,890
K23 · FY2004 · CA
Gene Modified Cell Lines as Vaccine for Pancreas Cancer$136,890
K23 · FY2003 · CA
Gene Modified Cell Lines as Vaccine for Pancreas Cancer$136,890
K23 · FY2002 · CA